Sizing the therapeutic potential of mRNA
mRNA vaccine technology has been in development for over two decades. Scientists’ ability to synthetically produce genetic material with instructions for making a protein and generating an immune response has exciting implications for the development of new vaccines and treatments. The ‘platform technology’ could hold the key to fixing some of the world’s health problems. The technology is safe, and it can be developed and scaled rapidly, with potentially transformative implications for human health. The technology could be used in immunotherapy to treat cancers and chronic infectious diseases – like HIV, hepatitis B and herpes – as well as autoimmune disorders and even for gene therapy. Its success in tackling a viral infection like Covid-19 means future pandemics could be prevented or managed faster by an mRNA response.